Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Revenue (2022 - 2025)

Historic Revenue for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $5000.0.

  • PAVmed's Revenue changed N/A to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $29000.0, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is 2214.52% up from last year.
  • As of Q3 2025, PAVmed's Revenue stood at $5000.0.
  • In the past 5 years, PAVmed's Revenue ranged from a high of $1.0 million in Q4 2023 and a low of $5000.0 during Q3 2025
  • In the last 4 years, PAVmed's Revenue had a median value of $166000.0 in 2023 and averaged $372846.2.
  • As far as peak fluctuations go, PAVmed's Revenue soared by 94078.95% in 2023, and later tumbled by 9938.71% in 2025.
  • Over the past 4 years, PAVmed's Revenue (Quarter) stood at $112000.0 in 2022, then soared by 836.61% to $1.0 million in 2023, then crashed by 99.05% to $10000.0 in 2024, then tumbled by 50.0% to $5000.0 in 2025.
  • Its Revenue was $5000.0 in Q3 2025, compared to $6000.0 in Q2 2025 and $8000.0 in Q1 2025.